Search Results
Itamar Raz, MD: Impact of Dapagliflozin on Fast Decline in eGFR
Dr. Itamar Raz: Need for New Guidelines in Diabetes
Silvio Inzucchi, MD: Implications of Initial EGFR Response to Empagliflozin
Dapagliflozin (Farziga) Slows Kidney Function Loss In IgA Nephropathy | Farxiga And Kidney Disease
From The Heart - (SGLT2 inhibitors) Ep#3: From diabetes to heart failure!
Dapagliflozin - A Nephrologist perspective by Dr Ratan Jha
Dapagliflozin - where it originated
Curalin - Profesor Itamar Raz
Kieran Docherty, MBChB: Impact of T2D Background Therapy on Dapagliflozin Benefit
SGLT2 inhibitor slows renal decline independent of glucose control
What are the results of using Dapagliflozin?
Kiersten Combs Discusses Scientific Research and Possible Future Indications for Dapagliflozin
